Efficacy of SL-701 in adult patients with glioblastoma multiforme.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs SL 701 (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 08 Mar 2018 Status changed from active, no longer recruiting to completed, according to a Stemline Therapeutics media release.
- 10 May 2017 According to a Stemline Therapeutics media release, updates from this trial are expected in 2018.
- 23 Mar 2017 According to a Stemline Therapeutics media release, dosing has been completed in this trial and patients with seond-line glioblastoma are being followed for survival.